Safety of Tedizolid as Suppressive Antimicrobial Therapy for Patients With Complex Implant-Associated Bone and Joint Infection due to Multidrug-Resistant Gram-Positive Pathogens: Results From the TediSAT Cohort Study
Pas d'abstract disponible
![international international](https://www.crioac-lyon.fr/wp-content/themes/crioac/library/images/cri-icon-international.png)
![free access free access](https://www.crioac-lyon.fr/wp-content/themes/crioac/library/images/cri-icon-libre-acces.png)